Alpha-1-antitrypsin deficiency: From genoma to liver disease. PiZ mouse as model for the development of liver pathology in human

Liver International

Volumn 35, Issue 1, 2015, Pages 198-206

  Giovannoni, Isabella ^a   Callea, Francesco ^a   Stefanelli, Marta ^a   Mariani, Riccardo ^a   Santorelli, Filippo M ^b   Francalanci, Paola ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

Author keywords

AAT globules hepatocellular carcinoma; Alpha 1 antitrypsin deficiency; Dedifferentiated cells; Transgenic mouse

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; GENOMIC DNA; GLUCOSE; GLUCOSE 6 PHOSPHATE; HYALIN; MESSENGER RNA; PREALBUMIN; TYROSINE AMINOTRANSFERASE; BIOLOGICAL MARKER; PRIMER DNA; SERUM ALBUMIN;

AGE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL BODY; CELL COUNT; CELL INCLUSION; CELLULAR DISTRIBUTION; CELLULAR SECRETION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; GENE EXPRESSION; GENE NUMBER; GENOTYPE PHENOTYPE CORRELATION; HAMARTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER GRANULOMA; LIVER HEMANGIOMA; LIVER HISTOLOGY; LIVER HYPERPLASIA; LIVER NECROSIS; LUNG METASTASIS; LYMPHOMA; MALE; MALLORY BODY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PIZ MOUSE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TRANSGENIC MOUSE; ANIMAL; BLOOD; DISEASE MODEL; GENETICS; HISTOLOGY; LIVER; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ALPHA-FETOPROTEINS; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DNA PRIMERS; GLUCOSE-6-PHOSPHATE; HISTOLOGICAL TECHNIQUES; IMMUNOHISTOCHEMISTRY; LIVER; MICE; PREALBUMIN; REAL-TIME POLYMERASE CHAIN REACTION; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC; TYROSINE TRANSAMINASE;

EID: 84921060278     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12504     Document Type: Article

References (31)

1. Huber R, Carrell RW. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry 1989; 28: 8951-66.
2. Greene CM, McElvaney NG. Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response. World J Gastrointest Pharmacol Ther 2010; 1: 94-101.
3. Crystal RG. Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy. J Clin Invest 1990; 85: 1343-52.
4. Norman MR, Mowat AP, Hutchinson DCS. Molecular basis, clinical consequences and diagnosis of alpha-1-antitrypsin deficiency. Ann Clin Biochem 1997; 34: 230-46.
5. World Health Organization Meeting. α1-antitrypsin deficiency: memorandum from a WHO meeting. Bull World Health Organ 1997; 75: 397-415.
6. Sveger T, Eriksson S. The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology 1995; 22: 514-7.
7. Perlmutter DH. Pathogenesis of chronic liver injury and hepatocellular carcinoma in alpha-1-antitrypsin deficiency. Pediatr Res 2006; 60: 233-8. Review.
8. Sifers RN, Carlson JA, Clift SM, et al. Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Nucleic Acids Res 1987; 15: 1459-75.
9. Brunt EM, Blomenkamp K, Ahmed M, et al. Hepatic progenitor cell proliferation and liver injury in a-1-antitrypsin deficiency. JPGN 2010; 51: 626-30.
10. Carlson JA, Rogers BB, Sifers RN, et al. Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. J Clin Invest 1989; 83: 1183-90.
11. Rudnick DA, Liao Y, An JK, et al. Analyses of hepatocellular proliferation in a mouse model of alpha-1-antitrypsin deficiency. Hepatology 2004; 39: 1048-55.
12. An JK, Blomenkamp K, Lindblad D, Teckman JH. Quantitative isolation of alphalAT mutant Z protein polymers from human and mouse livers and the effect of heat. Hepatology 2005; 41: 160-7.
13. Lindblad D, Blomenkamp K, Teckman J. Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model. Hepatology 2007; 46: 1228-35.
14. Perlmutter DH. Alpha-1-antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease-associated protein aggregates. Annu Rev Med 2011; 62: 333-45.
15. Thoolen B, Maronpot RR, Harada T, et al. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicol Pathol 2010; 38(7 Suppl.): 5S-81S.
16. Beier JI, Kaiser JP, Guo L, Martínez-Maldonado M, Arteel GE. Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis. Arch Biochem Biophys 2011; 510: 19-26.
17. Zhou M, Li P, Tan L, et al. Differentiation of mouse embryonic stem cells into hepatocytes induced by a combination of cytokines and sodium butyrate. J Cell Biochem 2010; 109: 606-14.
18. Geller SA, Nichols WS, Kim S, et al. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 alpha 1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. Hepatology 1994; 19: 389-97.
19. Callea F, Fevery J, Massi G, et al. Alpha-1-antitrypsin (AAT) and its stimulation in the liver of PiMZ phenotype individuals. A "recruitment-secretory block" ("R-SB") phenomenon. Liver 1984; 4: 325-37.
20. Zhou H, Ortiz-Pallardó ME, Ko Y, Fischer HP. Is heterozygous alpha-1-antitrypsin deficiency type PIZ a risk factor for primary liver carcinoma? Cancer 2000; 88: 2668-76.
21. Francalanci P, Santorelli FM, Saccani S, et al. Z and Malton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study. Liver Int 2009; 29: 1593-6.
22. Kvittingen EA, Rootwelt H, Berger R, Brandtzaeg P. Self-induced correction of the genetic defect in tyrosinemia type I. J Clin Invest 1994; 94: 1657-61.
23. Rudnick DA, Perlmutter DH. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease. Hepatology 2005; 42: 514-21.
24. Evans JG, Lake BG. The digestive system II: the hepatobiliary system. In: Turton J. and Hooson J., eds. Target Organ Pathology: A Basic Text. Taylor and Francis, London, 1998; 61-97.
25. Marcus NY, Brunt EM, Blomenkamp K, et al. Characteristics of hepatocellular carcinoma in a murine model of alpha-1-antitrypsin deficiency. Hepatol Res 2010; 40: 641-53.
26. Kakizoe S, Goldfarb S, Pugh TD. Focal impairment of growth in hepatocellular neoplasms of C57BL/6 mice: a possible explanation for the strain's resistance to hepatocarcinogenesis. Cancer Res 1989; 49: 3985-9.
27. Sancho-Bru P, Najimi M, Caruso M, et al. Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut 2009; 58: 594-603.
28. Bannasch P, Haertel T, Su Q. Significance of hepatic preneoplasia in risk identification and early detection of neoplasia. Toxicol Pathol 2003; 31: 134-9.
29. Popper H, Maltoni C, Selikoff IJ. Vinyl chloride-induced hepatic lesions in man and rodents. A comparison. Liver 1981; 1: 7-20.
30. Lee FI, Tharakan J, Vasudev KS, Isaacs PE. Malignant hepatic tumours associated with previous exposure to Thorotrast: four cases. Eur J Gastroenterol Hepatol 1996; 8: 1121-4.
31. Janciauskiene S, Dominaitiene R, Sternby NH, Piitulainen E, Eriksson S. Detection of circulating and endothelial cell polymers of Z and wild type alpha 1-antitrypsin by a monoclonal antibody. J Biol Chem 2002; 277: 26540-6.